SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 265.72 |
| Enterprise Value ($M) | 261.33 |
| Book Value ($M) | 44.03 |
| Book Value / Share | 0.91 |
| Price / Book | 6.03 |
| NCAV ($M) | 35.95 |
| NCAV / Share | 0.74 |
| Price / NCAV | 7.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.95 |
| Return on Assets (ROA) | -0.85 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.08 |
| Current Ratio | 6.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 100.85 |
| Assets | 108.93 |
| Liabilities | 64.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -64.21 |
| Net Income | -63.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -56.02 |
| Cash from Investing | -39.24 |
| Cash from Financing | 104.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Integrated Core Strategies (us) Llc | 1.70 | -64.81 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 2.00 | -46.12 | |
| 13G/A | Nantahala Capital Management, LLC | 9.99 | 77.07 | |
| 13G/A | Adage Capital Management, L.P. | 9.99 | ||
| 13G | Suvretta Capital Management, Llc | 9.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 437,063 | 1,328,487 | 32.90 | |
| 382,626 | 1,645,292 | 23.26 | |
| 596,936 | 2,213,606 | 26.97 | |
| 392,279 | 1,637,899 | 23.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABVC – ABVC BioPharma, Inc. | ACB – Aurora Cannabis Inc. |